Cargando…

The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across 11 distribution models in South Africa

BACKGROUND: Countries around the world seek innovative ways of closing their remaining gaps towards the target of 95% of people living with HIV (PLHIV) knowing their status by 2030. Offering kits allowing HIV self-testing (HIVST) in private might help close these gaps. METHODS: We analysed the cost,...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsimela, Katleho, Sande, Linda Alinafe, Mostert, Cyprian, Majam, Mohammed, Phiri, Jane, Zishiri, Vincent, Madondo, Celeste, Khama, Stephen, Chidarikire, Thato, d'Elbée, Marc, Hatzold, Karin, Johnson, Cheryl, Terris-Prestholt, Fern, Meyer-Rath, Gesine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287621/
https://www.ncbi.nlm.nih.gov/pubmed/34275873
http://dx.doi.org/10.1136/bmjgh-2021-005019
_version_ 1783723944373649408
author Matsimela, Katleho
Sande, Linda Alinafe
Mostert, Cyprian
Majam, Mohammed
Phiri, Jane
Zishiri, Vincent
Madondo, Celeste
Khama, Stephen
Chidarikire, Thato
d'Elbée, Marc
Hatzold, Karin
Johnson, Cheryl
Terris-Prestholt, Fern
Meyer-Rath, Gesine
author_facet Matsimela, Katleho
Sande, Linda Alinafe
Mostert, Cyprian
Majam, Mohammed
Phiri, Jane
Zishiri, Vincent
Madondo, Celeste
Khama, Stephen
Chidarikire, Thato
d'Elbée, Marc
Hatzold, Karin
Johnson, Cheryl
Terris-Prestholt, Fern
Meyer-Rath, Gesine
author_sort Matsimela, Katleho
collection PubMed
description BACKGROUND: Countries around the world seek innovative ways of closing their remaining gaps towards the target of 95% of people living with HIV (PLHIV) knowing their status by 2030. Offering kits allowing HIV self-testing (HIVST) in private might help close these gaps. METHODS: We analysed the cost, use and linkage to onward care of 11 HIVST kit distribution models alongside the Self-Testing AfRica Initiative’s distribution of 2.2 million HIVST kits in South Africa in 2018/2019. Outcomes were based on telephonic surveys of 4% of recipients; costs on a combination of micro-costing, time-and-motion and expenditure analysis. Costs were calculated from the provider perspective in 2019 US$, as incremental costs in integrated and full costs in standalone models. RESULTS: HIV positivity among kit recipients was 4%–23%, with most models achieving 5%–6%. Linkage to confirmatory testing and antiretroviral therapy (ART) initiation for those screening positive was 19%–78% and 2%–72% across models. Average costs per HIVST kit distributed varied between $4.87 (sex worker model) and $18.07 (mobile integration model), with differences largely driven by kit volumes. HIVST kit costs (at $2.88 per kit) and personnel costs were the largest cost items throughout. Average costs per outcome increased along the care cascade, with the sex worker network model being the most cost-effective model across metrics used (cost per kit distributed/recipient screening positive/confirmed positive/initiating ART). Cost per person confirmed positive for HIVST was higher than standard HIV testing. CONCLUSION: HIV self-test distribution models in South Africa varied widely along four characteristics: distribution volume, HIV positivity, linkage to care and cost. Volume was highest in models that targeted public spaces with high footfall (flexible community, fixed point and transport hub distribution), followed by workplace models. Transport hub, workplace and sex worker models distributed kits in the least costly way. Distribution via index cases at facility as well as sex worker network distribution identified the highest number of PLHIV at lowest cost.
format Online
Article
Text
id pubmed-8287621
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-82876212021-07-30 The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across 11 distribution models in South Africa Matsimela, Katleho Sande, Linda Alinafe Mostert, Cyprian Majam, Mohammed Phiri, Jane Zishiri, Vincent Madondo, Celeste Khama, Stephen Chidarikire, Thato d'Elbée, Marc Hatzold, Karin Johnson, Cheryl Terris-Prestholt, Fern Meyer-Rath, Gesine BMJ Glob Health Original Research BACKGROUND: Countries around the world seek innovative ways of closing their remaining gaps towards the target of 95% of people living with HIV (PLHIV) knowing their status by 2030. Offering kits allowing HIV self-testing (HIVST) in private might help close these gaps. METHODS: We analysed the cost, use and linkage to onward care of 11 HIVST kit distribution models alongside the Self-Testing AfRica Initiative’s distribution of 2.2 million HIVST kits in South Africa in 2018/2019. Outcomes were based on telephonic surveys of 4% of recipients; costs on a combination of micro-costing, time-and-motion and expenditure analysis. Costs were calculated from the provider perspective in 2019 US$, as incremental costs in integrated and full costs in standalone models. RESULTS: HIV positivity among kit recipients was 4%–23%, with most models achieving 5%–6%. Linkage to confirmatory testing and antiretroviral therapy (ART) initiation for those screening positive was 19%–78% and 2%–72% across models. Average costs per HIVST kit distributed varied between $4.87 (sex worker model) and $18.07 (mobile integration model), with differences largely driven by kit volumes. HIVST kit costs (at $2.88 per kit) and personnel costs were the largest cost items throughout. Average costs per outcome increased along the care cascade, with the sex worker network model being the most cost-effective model across metrics used (cost per kit distributed/recipient screening positive/confirmed positive/initiating ART). Cost per person confirmed positive for HIVST was higher than standard HIV testing. CONCLUSION: HIV self-test distribution models in South Africa varied widely along four characteristics: distribution volume, HIV positivity, linkage to care and cost. Volume was highest in models that targeted public spaces with high footfall (flexible community, fixed point and transport hub distribution), followed by workplace models. Transport hub, workplace and sex worker models distributed kits in the least costly way. Distribution via index cases at facility as well as sex worker network distribution identified the highest number of PLHIV at lowest cost. BMJ Publishing Group 2021-07-13 /pmc/articles/PMC8287621/ /pubmed/34275873 http://dx.doi.org/10.1136/bmjgh-2021-005019 Text en © World Health Organization 2021. Licensee BMJ. https://creativecommons.org/licenses/by-nc/3.0/igo/This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (CC BY NC 3.0 IGO (https://creativecommons.org/licenses/by-nc/3.0/igo/) ), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article’s original URL. Disclaimer: The author is a staff member of the World Health Organization. The author alone is responsible for the views expressed in this publication and they do not necessarily represent the views, decisions or policies of the World Health Organization.
spellingShingle Original Research
Matsimela, Katleho
Sande, Linda Alinafe
Mostert, Cyprian
Majam, Mohammed
Phiri, Jane
Zishiri, Vincent
Madondo, Celeste
Khama, Stephen
Chidarikire, Thato
d'Elbée, Marc
Hatzold, Karin
Johnson, Cheryl
Terris-Prestholt, Fern
Meyer-Rath, Gesine
The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across 11 distribution models in South Africa
title The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across 11 distribution models in South Africa
title_full The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across 11 distribution models in South Africa
title_fullStr The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across 11 distribution models in South Africa
title_full_unstemmed The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across 11 distribution models in South Africa
title_short The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across 11 distribution models in South Africa
title_sort cost and intermediary cost-effectiveness of oral hiv self-test kit distribution across 11 distribution models in south africa
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287621/
https://www.ncbi.nlm.nih.gov/pubmed/34275873
http://dx.doi.org/10.1136/bmjgh-2021-005019
work_keys_str_mv AT matsimelakatleho thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT sandelindaalinafe thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT mostertcyprian thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT majammohammed thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT phirijane thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT zishirivincent thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT madondoceleste thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT khamastephen thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT chidarikirethato thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT delbeemarc thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT hatzoldkarin thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT johnsoncheryl thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT terrisprestholtfern thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT meyerrathgesine thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT matsimelakatleho costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT sandelindaalinafe costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT mostertcyprian costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT majammohammed costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT phirijane costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT zishirivincent costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT madondoceleste costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT khamastephen costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT chidarikirethato costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT delbeemarc costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT hatzoldkarin costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT johnsoncheryl costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT terrisprestholtfern costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica
AT meyerrathgesine costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica